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Tamoxifen M fulvestrant for 6 days. β-actin was used as a reference for the loading control.
C) NOTCH4 -intracellular domain (ICD) protein levels were determined in wild-type and N4EX2 CRISPR clone by Western Blot. NB: A very small amount of NOTCH4-ICD was detected even though N4EX2 clone contains a frameshift deletion in both alleles, which we hypothesize to be due to a small amount of in-frame RNA produced by whole exon 3 skipping, i.e., by splicing of exon 1 donor site to the acceptor sites of exons that are in-frame. 
D)
B) Notch receptors and Notch ligands protein expression levels determined by Western Blot in
MCF-7 endocrine-resistant cells. β-actin was used as a reference for the loading control.
C) NOTCH4 intracellular domain expression levels determined by Western Blot in MCF-7
endocrine-resistant cells treated with GSI RO4929097 or control DMSO for 72h.
D)
Expression of HEY1 and HES1 and Notch transcriptional activity (10xCBF1-luciferase reporter) are inhibited by GSI RO4929097 (72h) in endocrine-resistant cells.
Data are represented as mean ± SEM. * p < 0.05, ** p < 0.01 
Patient-derived xenografts and in vivo experiments
For xenografting the BB3RC31 sample a single cell suspension of 1 million tumor cells in mammosphere media (DMEM/F12 media with L-Glutamine (Gibco) containing B27 supplement (Gibco; 12587) and 20 ng/ml EGF (Sigma)) mixed 1:1 with Matrigel (BD biosciences, 356234) was inoculated subcutaneously into dorsal flanks of NSG mice in a volume of 0.2 ml. BB3RC31
is a pleural effusion from a patient who also presented with liver, lung and abdominal metastasis.
For further clinico-pathological details of BB3RC31 please see Table S2 . M fulvestrant, respectively (Knowlden et al., 2003; McClelland et al., 2001 ). MCF7 resistant cell lines were authenticated by comparative karyotyping to ATCCderived MCF7.
Mammosphere colony assay
Single cell suspensions of freshly isolated ER+ primary and metastatic patient-derived samples were cultured for 7-9 days (primary cells) in mammosphere colony assays in the presence of Once virus-containing supernatants were collected, they were centrifuged at 400 g for 5min and filtered through 0.45 μm filter to remove cell debris. The viral supernatants were concentrated by ultracentrifugation using an AH-629 rotor (Sorvall Ultra Pro80, Sorvall) at 20000 rpm for 2h at 4°C. The viral pellets were resuspended in PBS and aliquots were stored at -80°C. MCF-7 cells were transduced with either lenti-or retro-viral particles in the presence of 8 μg/ml polybrene (Sigma). Stable transduced MCF-7 cells were selected by FACS based on GFP expression.
All cell lines were cultured at 37°C in 5% CO 2 and experiments were carried out at ~70% confluence.
NOTCH4 targeting using CRISPR-Cas9n technology
To generate MCF-7 clones with genomic alterations in NOTCH4, a double-nickase approach was used by expressing a D10A mutant version of Cas9 (Cas9 nickase) together with a pair of sgRNAs complementary to opposite strands of the targeted genomic locus. sgRNA oligo sequences (sgRNA-A, 5'-ACCTGCCTGAGCCTGTCTCT-3'; sgRNA-B, 3'-TCTTGGGACACGGTTACCT-5') targeting exon 2 of NOTCH4 gene were designed using the CRISPR design tool (http://crispr.mit.edu/) - Figure S2D . sgRNA-coding sequences were cloned into pSpCas9n (BB)-2A-GFP (Addgene, PX461) vector. MCF-7 cells were co-transfected with PX461-sgRNA-A and PX461-sgRNA-B plasmids using X-tremeGENE Transfection reagent (Roche, 06366244001). Two days post-transfection, GFP-positive cells were directly FACS sorted as single cells into 96-well plates. After 14 days in culture, clones were screened for CRISPR-mediated indels. Genomic DNA was extracted using the Wizard Genomic DNA Purification Kit (Promega, A1120) and genotyping PCR was performed using a set of primers flanking the CRISPR target site (forward 5'-GGGTACCATGTGGAGAGTGG-3'; reverse 5'-CACAAGAAGCTGGGTGTCAA-3'). PCR products purified with QIAquick PCR Purification Kit (Qiagen, 28104) were cloned into pGEM-T Easy vector and then Sanger sequenced using T7 sequencing primer. Absence of wild-type alleles was confirmed by using a specific restriction enzyme for target sequence (BanI, Biolabs R0118S). Proteins were extracted and separated on 10% SDS-PAGE gel. Membranes were incubated with anti-NOTCH4 (Santa Cruz, sc-5594) and anti-β-actin (Sigma, A1978) antibodies.
Cancer tissue and cells analysis
Tissue microarrays (TMAs) were constructed from all formalin fixed and paraffin embedded Protein expression analysis using western-blot
Proteins were extracted with Protein Lysis Buffer (25mM HEPES, 50mM NaCl, 30mM NaPP, 50mM NaF, 1% Triton-X-100, 10% Glycerol, 5mM EDTA, Protease Inhibitor cocktail, 1μM PMSF). Lysates were placed on a rotator for 1 hour at 4°C, then were centrifuged at 10000g at 4°C for 10min, and supernatants were collected. Protein concentrations were assessed using the Horseradish peroxidase-conjugated secondary antibodies (Dako, P0447, P0448, P0449) were incubated for 1h at room temperature. Proteins were visualized with Luminata Classico or Luminata Forte (Millipore, WBLUC0100, WBLUF0100) by exposing the membranes to X-ray films (HyperfilmTM MP, Amersham).
Notch Transcriptional assay
To measure the activation of Notch dependent transcription, cells were transfected with CBF1 firefly luciferase reporter (containing 10 copies of a CBF1 consensus sequence) and CMV-Renilla luciferase reporter. Plasmids were incubated with X-tremegene (Roche, 06366244001) in a ratio of 3:1 (μl of X-tremegene:μg of DNA) in OptiMEM (Life Technologies, 11058-021) for 15 minutes, before addition to the culture media. After 48 hours cells were lysed with 1x Passive lysis buffer (5x, Promega, E 1941), put on the rocker for 15 minutes and luminescence was assayed with the Dual-Glo Luciferase assay system (Promega, E2920) following manufacturer's instructions. Luciferase activity was measured using a luminometer (Promega, Glomax Multi+ Detection System with Instinct Software). Luminescence of the firefly luciferase was normalised to that of the renilla luciferase.
Growth assay (SRB assay)
6000 cells were seeded per well in a 96 well-plate at least in triplicate for each condition used.
Plates were incubated in a humidified incubator at 37°C with 5% CO 2 and an SRB assay was performed at different time points to assess cellularity. Briefly, cells were fixed with 25μl/well of 50% (w/v) trichloroacetic (TCA) and incubated at 4°C for a minimum of 1hour. Fixed cells were washed 5 times with water and left to air dry. Cells were then stained with 100μl/well of 0.4% (w/v) Sulforhodamine B (SRB) dissolved in 1% acetic acid for 30 minutes at room temperature.
Residual SRB was washed away with 3 washes of 1% acetic acid and plates were left to air dry.
Finally, SRB was solubilized with 100μl/well of 10mM Tris-base (pH 10.5) for 20 minutes at room temperature and absorbance was measured at 490 nm with an automated plate reader (BioTek ELx800).
Notch gene expression signature
Gene expression data was summarised with Ensembl alternative CDF (Dai et al., 2005, Nucleic Acids Res 33:e175) and normalised with RMA, before integration using ComBat (Johnson et al., 2007, Biostatistics; 8: 118-127) to remove dataset-specific bias.
